Title : Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?

Pub. Date : 2013 Jul

PMID : 23394475






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study aimed to investigate the allele and genotype frequencies of single nucleotide polymorphisms (SNPs) of SLCO1B3 (T334G) and CYP3A5*3 in CML patients undergoing imatinib treatment and to determine whether SNPs of these two genes could predict the response of imatinib therapy in CML patients. Imatinib Mesylate solute carrier organic anion transporter family member 1B3 Homo sapiens
2 This study aimed to investigate the allele and genotype frequencies of single nucleotide polymorphisms (SNPs) of SLCO1B3 (T334G) and CYP3A5*3 in CML patients undergoing imatinib treatment and to determine whether SNPs of these two genes could predict the response of imatinib therapy in CML patients. Imatinib Mesylate solute carrier organic anion transporter family member 1B3 Homo sapiens